Instalab
logoInstalab

Actin Peptide IgA

Blood Test
One extra clue that celiac gut damage may still be active after tTG and endomysial antibodies have gone quiet.
4.9 (3,228 reviews)
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Actin Peptide IgA test?

This test is most useful if any of these apply to you.

Managing Celiac on a Gluten-Free Diet
You've cut gluten and want one more clue about whether your gut lining is healing, not just quieter symptoms.
Still Symptomatic Despite the Diet
Your tTG or endomysial antibodies look fine, but symptoms linger and you worry villous damage is still there.
Living With Celiac and High Liver Enzymes
You have celiac disease plus unexplained ALT or AST elevations and want to know if the liver needs a closer look.
Facing Another Biopsy
Your biopsy was unclear or hard to repeat, and you want an extra signal about severe gut-lining damage.

About Actin Peptide IgA

This test measures IgA antibodies against actin in blood. Actin helps cells hold their shape. In celiac disease, the antibody tends to show up when the small-intestine lining has more severe injury and to fade after gluten is removed and the lining heals. It is a poor first screen for celiac disease. Its narrower use is as a rough signal of gut-lining damage in someone whose celiac story already makes sense.

The useful edge is in follow-up. Standard celiac antibodies can go back to normal even when the villi are still flattened. In one small treated group, anti-actin IgA was positive in the three people whose villi were still flattened while tTG IgA and endomysial antibodies were negative. The other nine had normal villi and negative anti-actin IgA. That is a small signal, not a settled monitoring strategy.

What This Antibody Actually Is

Your cells have an internal scaffold. One of its main parts is actin. IgA anti-actin antibodies are immune proteins your body makes against actin. IgA is the antibody class that guards wet surfaces, including the gut lining. This test measures the IgA form in serum from a blood draw. It targets actin as a filament, not a small muscle-building peptide.

Why would a gut disease produce an antibody against a cell-scaffold protein? The best explanation is injury. Gluten-triggered immune attack can disrupt the actin network in intestinal surface cells. Once actin is exposed to the immune system, some people make antibodies against it. Because actin is found across the body, this antibody cannot prove celiac disease by itself.

Celiac Disease and Damage Severity

The small intestine absorbs food through tiny folds called villi. Celiac disease can flatten them. Anti-actin IgA rises most often with that flattening, especially when the damage is severe.

In the largest study, 205 newly diagnosed children and adults with biopsy-proven celiac disease were compared with 161 controls. The test was positive in about 80 of 100 people with celiac disease and negative in about 85 of 100 controls. Within the celiac group, it was positive in about 69 of 100 with milder biopsy damage and about 85 of 100 with severe damage. Higher antibody levels tended to go with flatter villi.

Who Was StudiedWhat Was ComparedWhat They Found
205 newly diagnosed children and adults with celiac disease, plus 161 controlsAnti-actin IgA against biopsy-confirmed celiac disease and control samplesPositive in about 80 of 100 with celiac disease; negative in about 85 of 100 controls
The same celiac group, split by biopsy severityMilder versus severe gut-lining damagePositive in about 69 of 100 with milder damage and about 85 of 100 with severe damage
Twelve treated celiac patients with persistent symptomsAnti-actin IgA, tTG IgA, endomysial antibodies, and repeat biopsyPositive in the three with persistent villous atrophy; negative in the nine whose villi had normalized

Source: Carroccio et al., 2007.

What this means for you: a positive result points toward more severe gut-lining injury in the right celiac context. It does not diagnose celiac disease. A negative result lowers concern, but it does not prove the lining has healed, because the test misses many celiac cases, especially milder injury, and how many it misses depends heavily on the lab method.

Damage the Standard Tests Miss

The usual celiac blood tests, tTG IgA and endomysial antibodies, are strong tests at diagnosis when you are eating gluten. They are weaker as healing tests once you are on a gluten-free diet. In a meta-analysis of follow-up biopsies, tTG IgA detected only about half of people with persistent villous atrophy, and endomysial antibodies detected slightly fewer.

Anti-actin IgA is a candidate add-on here, not a replacement. The treated-patient evidence is tiny: three persistent-damage cases in the Carroccio study. Still, the direction makes biological sense because the antibody follows villous injury more closely than tTG does in several celiac studies.

The Liver Connection

Antibodies against actin also matter in autoimmune hepatitis, where the immune system attacks the liver. Most liver testing focuses on smooth muscle or F-actin antibodies, usually IgG rather than the IgA form used in celiac workups. Those liver findings don't transfer cleanly to this test.

No study shows that the celiac IgA anti-actin test predicts autoimmune hepatitis, so a positive result is not a liver signal on its own. But if you have celiac disease, a positive anti-actin IgA, and unexplained ALT or AST elevations, it is reasonable to check the liver pattern directly and consider a hepatology referral if enzymes stay high or other autoimmune-hepatitis markers are present.

How to Read Repeat Results

One result is blunt. A repeat result from the same lab can be more useful, because the assay and cutoff vary by manufacturer. A falling result after a strict gluten-free diet fits healing. A rising or persistently positive result fits ongoing gut-lining injury, hidden gluten exposure, or another actin-antibody source.

Do not let a negative result overrule symptoms, iron deficiency, weight loss, or a biopsy concern. Anti-actin IgA can be absent even with severe damage. The stronger claim is the positive one: in the right setting, it can add weight to the case that the lining is still injured.

When a Result Can Mislead You

  • You have already cut gluten: if you are using the test to help diagnose celiac disease, gluten avoidance can make antibodies fade. For diagnosis, celiac blood testing is meant to happen while you are eating gluten. For follow-up after a confirmed diagnosis, the question is different: whether the antibody is falling with healing.
  • The antigen the lab uses: celiac anti-actin antibodies often target bundled actin filaments. Some assays use a straighter, single-actin form. That mismatch can make the test read negative even when gut damage is present.
  • The assay method: ELISA and immunofluorescence tests do not perform the same way, and sensitivity depends heavily on which one is used. Results from one lab may not compare cleanly with results from another.
  • It is not celiac-specific: anti-actin signals can appear in autoimmune hepatitis and in some disease-control groups, so a positive result outside a celiac workup needs a broader explanation.
  • Total IgA is low: because this is an IgA test, IgA deficiency can make the result look falsely low or negative.
  • No shared clinical cutoff: labs use different assays and thresholds, so compare repeat values from the same lab when you can.

What to Do With an Unexpected Result

If you do not already have a celiac diagnosis, pair this with tTG IgA and total IgA. If total IgA is low, use IgG-based celiac tests such as DGP IgG or tTG IgG. Stay on gluten until the diagnostic workup is finished unless you have been told not to.

Biopsy is still the definitive step for most adults and for many unclear cases. In selected children with very high tTG IgA and positive endomysial antibodies, guidelines allow a no-biopsy diagnosis. Anti-actin IgA is not the test that makes that call.

If you already have celiac disease and this is positive while your standard antibodies are normal, treat it as a reason to check whether your gut has healed. That may mean a careful look for hidden gluten, repeat standard serology, or a discussion about follow-up biopsy. If liver enzymes are rising too, check liver causes in parallel.

What Moves This Biomarker

Evidence-backed interventions that affect your Actin Peptide IgA level

↓ Decrease
Strict gluten-free diet after confirmed celiac disease
In people with celiac disease who are positive at baseline, anti-actin IgA often falls after gluten is removed and the gut lining heals. In one study, anti-microfilament IgA was the related anti-actin measurement; it disappeared in 20 people after a gluten-free diet and biopsy recovery. In the Carroccio follow-up group, all nine people with normal villi were anti-actin IgA negative. A falling result supports healing, but it should not replace symptoms, nutrition labs, standard celiac antibodies, or biopsy when those are needed.
DietStrong Evidence
↑ Increase
Gluten exposure in untreated or poorly controlled celiac disease
In celiac disease, ongoing gluten exposure keeps the immune injury active. Anti-actin IgA is more often positive when villi are severely flattened than when injury is mild. A high or rising value can fit active damage, but the test misses many cases and cannot measure gluten exposure by itself.
DietModerate Evidence

Frequently Asked Questions

References

13 studies
  1. Carroccio a, Brusca I, Iacono G, Alessio M, Sonzogni a, Di Prima L, Barrale M, Ottomano C, Ambrosiano G, Teresi S, D'angelo a, Pirrone G, Cefalu B, Scalici C, La Chiusa SMDigestive and Liver Disease2007
  2. Bazzigaluppi E, Parma B, Tronconi G, Corsin P, Albarello L, Mora S, Barera GItalian Journal of Pediatrics2010
  3. Granito a, Muratori P, Cassani F, Pappas G, Muratori L, Agostinelli D, Veronesi L, Bortolotti R, Petrolini N, Bianchi FB, Volta UClinical & Experimental Immunology2004
  4. Clemente MG, Musu MP, Frau F, Brusco G, Sole G, Corazza GR, De Virgiliis SGut2000
  5. Porcelli B, Ferretti F, Vindigni C, Scapellato C, Terzuoli LJournal of Clinical Laboratory Analysis2013